Bold Therapeutics Inc.
$1,464,715.00 CAD
≈ 19 Canadians' average pay for a year
- Department
- National Research Council Canada
- Recipient country
- Canada
- Fiscal year
- 2020-2021
- Agreement period
- November 25, 2020 – December 31, 2021
- Reference
- nrc-cnrc:172-2020-2021-Q3-961802
Published purpose
BOLD-100 is a first-in-class, clinical-stage investigational therapy being developed for the treatment of patients with cancer and viral infections, including COVID-19. BOLD-100 has previously been shown to have antiviral activity against SARS-CoV-2 in an vitro model. This project focuses on completing the preclinical data package, preparing for clinical trial in COVID-19, and supporting manufacturing.
Community tags
Tags are applied by readers, not by this site. One tag per person per record.
Good value
Local impact
Needs context
Questionable
Success story
Wasteful
View official source record
Imported August 3, 2026 from open.canada.ca Grants & Contributions